For: | Wang YJ, Xie XL, Liu HQ, Tian H, Jiang XY, Zhang JN, Chen SX, Liu T, Wang SL, Zhou X, Jin XX, Liu SM, Jiang HQ. Prostaglandin F2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F2α-dependent and F2α-independent mechanism. World J Gastroenterol 2023; 29(39): 5452-5470 [PMID: 37900995 DOI: 10.3748/wjg.v29.i39.5452] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i39/5452.htm |
Number | Citing Articles |
1 |
Wen-Yu Luan, Hao Lin, Yan-Dong Miao. Recommendations for articles and reviews in colorectal cancer-related research at the year-end of 2023. World Journal of Gastroenterology 2024; 30(30): 3548-3553 doi: 10.3748/wjg.v30.i30.3548
|
2 |
Zhangjie Wang, Feiyu Bai, Yufeng Chen, Xuanhui Liu, Zeping Huang, Qiqi Zhu, Xiaojian Wu, Zerong Cai. Does the initial treatment of primary tumor impact prognosis after recurrence in locally advanced rectal cancer? Results from a retrospective cohort analysis. International Journal of Colorectal Disease 2024; 39(1) doi: 10.1007/s00384-024-04721-9
|
3 |
Jianzhou Jiang, Yajie Ma, Lele Yang, Shurui Ma, Zixuan Yu, Xinyi Ren, Xiangya Kong, Xinlei Zhang, Dong Li, Zhongyang Liu. CTR-DB 2.0: an updated cancer clinical transcriptome resource, expanding primary drug resistance and newly adding acquired resistance datasets and enhancing the discovery and validation of predictive biomarkers. Nucleic Acids Research 2025; 53(D1): D1335 doi: 10.1093/nar/gkae993
|